Pifithrin-alpha induced p53 inhibition does not affect liver regeneration after partial hepatectomy in mice

Journal of Hepatology

Volumn 43, Issue 5, 2005, Pages 829-835

  Eipel, Christian ^a   Schuett, Harald ^a   Glawe, Claudia ^a   Bordel, Reingart ^a   Menger, Michael D ^b   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

BrdU; PCNA; Proliferation; Resection; TUNEL

Indexed keywords

BROXURIDINE; CYCLINE; PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER REGENERATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HEPATECTOMY; HEPATOCYTES; IN SITU NICK-END LABELING; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; THIAZOLES; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 26244463363     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.04.018     Document Type: Article

References (24)

1. G.K. Michalopoulos, and M.C. deFrances Liver regeneration Science 276 1997 60 66
2. A.H. Haber, K.L. Mohn, R.H. Diamond, and R. Taub Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration J Clin Invest 91 1993 1319 1326
3. N. Fausto Liver regeneration J Hepatol 32 2000 19 31
4. G.M. Higgins, and R.M. Anderson Experimental pathology of the liver; I Restoration of the liver by the white rat following partial surgical removal. Arch Pathol 12 1931 186 202
5. N.L. Thompson, J.E. Mead, L. Braun, M. Goyette, P.R. Shank, and N. Fausto Sequential protooncogene expression during rat liver regeneration Cancer Res 46 1986 3111 3117
6. C. Prives, and P.A. Hall The p53 pathway J Pathol 187 1999 112 126
7. V. Arora, and P.L. Iversen Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo Drug Metab Dispos 28 2000 131 138
8. Y. Inoue, T. Tomiya, M. Yanase, M. Arai, H. Ikeda, and K. Tejima p53 may positively regulate hepatocyte proliferation in rats Hepatology 36 2002 336 344
9. A.K. Greene, and M. Puder Partial hepatectomy in the mouse: technique and perioperative management J Invest Surg 16 2003 99 102
10. P.G. Komarov, E.A. Komarova, R.V. Kondratov, K. Christov-Tselkov, J.S. Coon, and M.V. Chernov A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy Science 285 1999 1733 1737
11. N. Assy, Y. Gong, M. Zhang, N.M. Pettigrew, D. Pashniak, and G.Y. Minuk Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats J Lab Clin Med 131 1998 251 256
12. N. Assy, and G.Y. Minuk Liver regeneration: methods for monitoring and their applications J Hepatol 26 1997 945 952
13. C.C. Furnus, A.M. Inda, L.B. Andrini, M.N. Garcia, A.L. Garcia, and A.F. Badran Chronobiology of the proliferative events related to angiogenesis in mice liver regeneration after partial hepatectomy Cell Biol Int 27 2003 383 386
14. N. Fausto, J.E. Mead, L. Braun, N.L. Thompson, M. Panzica, and M. Goyette Proto-oncogene expression and growth factors during liver regeneration Symp Fundam Cancer Res 39 1986 69 86
15. A.I. Su, L.G. Guidotti, J.P. Pezacki, F.V. Chisari, and P.G. Schultz Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice Proc Natl Acad Sci USA 99 2002 11181 11186
16. J. Rozga Hepatocyte proliferation in health and in liver failure Med Sci Monit 8 2002 RA32 RA38
17. J. Foley, T. Ton, R. Maronpot, B. Butterworth, and T.L. Goldsworthy Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats Environ Health Perspect 101 1993 199 205
18. T. Schaefer, C. Scheuer, K. Roemer, M.D. Menger, and B. Vollmar Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death FASEB J 17 2003 660 667
19. P.J. Murphy, M.D. Galigniana, Y. Morishima, J.M. Harrell, R.P. Kwok, and M. Ljungman Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation J Biol Chem 279 2004 30195 30201
20. C.O. Bellamy, A.R. Clarke, A.H. Wyllie, and D.J. Harrison p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage FASEB J 11 1997 591 599
21. J.H. Albrecht, A.H. Meyer, and M.Y. Hu Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration Hepatology 25 1997 557 563
22. Y. Suliman, O.G. Opitz, A. Avadhani, T.C. Burns, W. El-Deiry, and D.T. Wong p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice Cancer Res 61 2001 6467 6473
23. D.G. Rudmann, and S.K. Durham Utilization of genetically altered animals in the pharmaceutical industry Toxicol Pathol 27 1999 111 114
24. G.S. Duncan, D.P. Andrew, H. Takimoto, S.A. Kaufman, H. Yoshida, and J. Spellberg Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions J Immunol 162 1999 3022 3030